Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60612


Purpose:

The primary objective of the study is to assess the safety of CC-1088 to patients with myelodysplastic syndromes (MDS).


Criteria:

- Eligible patients must have a diagnosis of MDS of at least 12 weeks that is not therapy related. - Patient must be able to adhere to the study visit schedule and other protocol requirements. - Patient must understand and voluntarily sign an informed consent document. - Women of childbearing potential (WCBP) must have a negative serum or urine pregnancy test. - Women must not be pregnant or lactating.


NCT ID:

NCT00045786


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60612
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 12, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.